AKT1 and carcinoma: A patient case with simultaneous mutations of all three Akt-phosphorylation sites (T32, S253, S315), like our mouse model, has not been reported yet, but a S253F Akt-phosphorylation site mutation has been identified in carcinoma patients [29, 30].